Foundation IRCCS San Matteo Hospital   Report issue

Academic/Hospital Phase 2
Founded: Pavia Italy (1449)

Organization Overview

First Clinical Trial
2014
NCT02102711
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Catherine Klersy | Foundation IRCCS San Matteo Hospital | IRCCS Fondazione Policlinico San Matteo | Laboratorio Sperimentale di Immunologia e Trapianti, Oncoematologia Pediatrica, Fondazione IRCCS Policlinico S. Matteo, Pavia | Lidia Decembrino | University Hospital San Matteo in Pavia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Amyloidosis (Phase 2)

Glaucoma (Phase 2)

Glaucoma, Open-Angle (Phase 2)

Immunoglobulin Light-chain Amyloidosis (Phase 2)

Infarction (Phase 2)

Myocardial Infarction (Phase 2)

Nephrosis (Phase 2)

Nephrotic Syndrome (Phase 2)

Pancreatic Neoplasms (Phase 2)

ST Elevation Myocardial Infarction (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 10